Artificial Intelligence/Machine Learning Modeling on Time to Palliative Care Review in an Inpatient Hospital Population
The Impact of Artificial Intelligence/Machine Learning (AI/ML) on Time to Palliative Care Review in an Inpatient Hospital Population
1 other identifier
interventional
2,231
1 country
1
Brief Summary
Investigators are testing whether machine learning prediction models integrated into a health care model will accurately identify participants who may benefit from a comprehensive review by a palliative care specialist, and decrease time to receiving a palliative care consult in an inpatient setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2019
CompletedFirst Posted
Study publicly available on registry
June 6, 2019
CompletedStudy Start
First participant enrolled
August 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2020
CompletedDecember 30, 2020
December 1, 2020
1.3 years
June 3, 2019
December 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Timely identification for need of palliative care
Measured as time in hours to the electronic record of consult by the palliative care team in the inpatient setting.
12 months
Secondary Outcomes (10)
The number of inpatient palliative care consults
12 months
Timely identification for need of palliative care per unit
12 months
Transition time to hospice-designated bed
12 months
Time to hospice designation
12 months
Emergency Department visit within 30 days of discharge
12 months
- +5 more secondary outcomes
Study Arms (2)
Control Tower Intervention
EXPERIMENTALFor participants in the intervention arm, the results of the prediction model will be presented through a GUI interface hereby known as the Control Tower. Participants receive scores from Control Tower (0-100; higher score indicating increased need) for palliative care and are subsequently ranked from highest to lowest. Red (7 or greater) is considered high risk. The intervention will include a Control Tower operator who will interact with the inpatient palliative care consult service. The operator will monitor the Control Tower during weekday normal business hours and select daily a cohort of participants in the intervention units with the highest need of palliative care review. The final list of participants will then be sent to palliative care. The palliative care team who is on service will also assess the need for each participants, and those participants which they agree could benefit they will approach the attending clinical team to suggest a palliative care referral.
Standard of Care
NO INTERVENTIONFor participants who are not in an intervention period they will receive the standard of care commensurate with their clinical unit. This is feasible given that this is a pragmatic clinical trial where the investigators can easily control the communication between the control tower operator and palliative care team to prevent any contamination between clusters. In addition to the usual source of care control the investigators intentionally have calibrated the prediction model and the Control Tower review to match the average capacity of the palliative care service, knowing that that the team will still receive palliative care consults through the traditional pathway i.e. the attending care team consulting palliative care directly.
Interventions
A workstation and software tool that extracts medical data from Mayo's data mart and electronic health record, and processes it through a prediction model that determines whether a patient is suited for a palliative care consult.
Eligibility Criteria
You may qualify if:
- Admitted to Mayo Clinic St. Mary's Hospital and Methodist Hospital during August 19, 2019 - August 19, 2020.
- Once a day Monday through Friday, the CT operator selects 12 patients from all of the nursing units that are participating in the trial (whether or not they are currently in the intervention group) with palliative scores of at least 7 (out of 100), i.e., those that are high risk and displayed as red in the CT GUI (unless they are already being seen by palliative care.)
You may not qualify if:
- Once the CT operator identifies 12 appropriate patients or once they reaches the end of the high-risk patients (score of 7 or higher) they stop.
- We will exclude all patients who do not provide research authorization to review their medical records for general research studies in accordance with Minnesota Statute 144.335.
- We will exclude patients under the age of 18 years of age.
- We will exclude patients previously seen by Palliative care during the index hospital visit (i.e., green icon within CT user interface regardless of score)
- We will exclude patient who no longer have an active encounter (patients who have died or patients who have transferred to another facility are excluded) at the time of the review
- We will exclude patients currently enrolled with the Hospice service at Mayo
- We will exclude patients currently enrolled in the Palliative Homebound program (an alternative healthcare model at Mayo)
- We will exclude patients who are about to be discharged in the next 24 hours through indication of note
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55906, United States
Related Publications (1)
Wilson PM, Philpot LM, Ramar P, Storlie CB, Strand J, Morgan AA, Asai SW, Ebbert JO, Herasevich VD, Soleimani J, Pickering BW. Improving time to palliative care review with predictive modeling in an inpatient adult population: study protocol for a stepped-wedge, pragmatic randomized controlled trial. Trials. 2021 Sep 16;22(1):635. doi: 10.1186/s13063-021-05546-5.
PMID: 34530871DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Jon O Ebbert, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 3, 2019
First Posted
June 6, 2019
Study Start
August 19, 2019
Primary Completion
November 18, 2020
Study Completion
December 20, 2020
Last Updated
December 30, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share